Quarter
Charts
πŸ‡ΊπŸ‡ΈUS Markets

HealthLynked Corp. β€” Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) Β· sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 β€” 27 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings Β· last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$310K↓-49.9%β€”β€”β€”
2025-09-30$389K↓-34.2%$-852K↑+56.8%-136.3%
2025-06-30$592K↓-25.5%$-701K↑+54.5%-73.5%
2025-03-31$774K↓-22.9%$-1M↑+24.3%-79.7%
2024-12-31$619K↓-33.5%β€”β€”β€”
2024-09-30$590K↓-55.7%$-2M↓-1028.0%-283.2%
2024-06-30$795K↓-53.3%$-2M↓-53.5%-135.8%
2024-03-31$1M↓-42.8%$-1M↓-195.6%-117.3%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings Β· FY2025 (Q4)

Revenue
$310K
↓-49.9% -$309K YoY

Earnings surprise Β· last 8 quarters

YoY % change Β· proxy for analyst surprise until estimates land

EPS history Β· last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted β€” flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends Β· 40 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-24.5pts
75.5%
Operating Margin↑+146.9pts
-136.3%
Net Margin↑+115.1pts
-219.2%

Go deeper